The global bisacodyl market is anticipated to grow at a considerable CAGR of 5.9 % during the forecast period (2022- 2028). Innovations coupled up with many leading technological advancements and key acquisitions are anticipated to drive the global bisacodyl over the forecast period. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in July 2020, LMG Pharma acquired formulation development and drug product contract manufacturing process from Nexgen Pharma Inc. The combination brings together LGM Pharma's global leadership in Active Pharmaceutical Ingredient (API), sourcing, distribution, and supply chain management with Nexgen Pharma Inc. drug product contract development and manufacturing services. Furthermore, in February 2020 Dr. Reddy’s Laboratories, Ltd acquired selected divisions of Wockhardt, Ltd branded generic business in India and few other international territories of Nepal, Srilanka, Bhutan, and the Maldives. Multiple therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, pain, and vaccines have been transferred to Dr. Reddy’s Laboratories Ltd along with related sales and marketing teams.
Browse the full report description of “Global Bisacodyl Market Size, Share & Trends Analysis Report by Type (High Purity and Low Purity), by Application (Constipation and Neurogenic Bowl Dysfunction) Forecast 2022-2028.” at https://www.omrglobal.com/industry-reports/bisacodyl-market
Moreover, in May 2021, a Duke Scientist developed an artificial intelligence tool that can be added to the standard toilet to help analyze patient’s stool and give gastroenterologists the information they need to provide appropriate treatment for chronic issues such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). The work is in the process by Dukes University’s Centre for Water, Sanitisation, Hygiene and Infectious Disease (wash-AID). Thus advancement in technology is expected to propel the growth of the global bisacodyl market.
Market Coverage
• The market number available for – 2022-2028
• Base year- 2020
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Cipla ltd., Dr. Reddy’s Laboratories, GlaxoSmithKline plc, LMG Pharma, Sanofi S.A among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Bisacodyl Market Report Segment
By Type
• High purity
• Low purity
By Application
• Constipation
• Neurogenic Bowel Dysfunction
Global Bisacodyl Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/bisacodyl-market